Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer
Abstract The role of germline genetics in adjuvant aromatase inhibitor (AI) treatment efficacy in ER-positive breast cancer is poorly understood. We employed a two-stage candidate gene approach to examine associations between survival endpoints and common germline variants in 753 endocrine resistanc...
Сохранить в:
| Главные авторы: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Nature Portfolio
2025-02-01
|
| Серии: | npj Breast Cancer |
| Online-ссылка: | https://doi.org/10.1038/s41523-025-00733-y |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|
